October 28, 2019 at 8:53 AM EDT CAMBRIDGE, Mass. and ROSTOCK, Germany, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Centogene B.V. (“Centogene” or the “Company”), a commercial-stage company focused on rare …
News
Neurimmune and TVM Capital Life Science Announce the Initiation of AL-S Pharma’s Phase 1 Study of AP-101 for the Treatment of ALS
Schlieren, Switzerland – October 16, 2019 – AL-S Pharma AG, a biotech company jointly founded and financed by Neurimmune and TVM Capital Life Science, announced today enrollment of the first patient …
Lilly’s REYVOW™ (lasmiditan), The First and Only Medicine in a New Class of Acute Treatment for Migraine, Receives FDA Approval
The approval of REYVOW is significant because it represents the first new class of acute migraine treatment approved by the FDA in more than two decades INDIANAPOLIS, Oct. 11, 2019 /PRNewswire/ -- …
Emovi Announces Results of Clinical Trial to Manage Knee Osteoarthritis with KneeKGTM
Results demonstrates that use of KneeKG in patients with osteoarthritis reduces pain, improves patient quality of life, and may reduce need for unnecessary surgery. Montreal, Quebec (October 1st, …
Proteon Therapeutics and ArTara Therapeutics Agree to Combine
September 23, 2019 Transaction to Create NASDAQ-Listed Rare and Specialty Disease Therapeutic Company Focused on Immunology and Metabolic Disorders $42.5M Concurrent Financing to be Led by a …
BIO Deutschland – Biotechnologie-Branchenverband wählt Dr Hubert Birner in den Vorstand
Berlin (17. September 2019) – Der Branchenverband der Biotechnologie-Industrie, BIO Deutschland e. V., hat gestern während der 16. ordentlichen Mitgliederversammlung in Berlin einen neuen Vorstand für …